Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07142304 · ClinicalTrials.gov registry record · NA
The Lilac Device Trial
A NA study of Chemotherapy Induced Peripheral Neuropathy (CIPN), sponsored by Luminate Medical.
- Recruiting
- Registry status
- NA
- Development phase
- 142
- Enrollment target
- 8
- Study locations
NCT07142304 is a NA study of Chemotherapy Induced Peripheral Neuropathy (CIPN) that is actively recruiting participants, run by Luminate Medical. The registered enrollment target is 142 participants. The trial reports 8 study locations across 7 states.
The verdict
NCT07142304, a NA study of Chemotherapy Induced Peripheral Neuropathy (CIPN), is actively recruiting participants, sponsored by Luminate Medical.
- RECRUITING
- Registry status
- NA
- Development phase
- 142 participants
- Enrollment target
- 8
- Study locations
Study Summary
Chemotherapy drugs, used in the treatment of cancer, have the potential of inducing peripheral neuropathy (PN) as a side effect. This side effect is commonly referred to as CIPN, or chemotherapy-induced peripheral neuropathy. The Lilac Glove and Boot devices apply a low pressure across the surface of the hands and feet, respectively, to reduce access of chemotherapy to the peripheral nerves on the hands and feet. The small amount of pressure reduces the level of chemotherapy reaching the peripheral nerves, hence increasing the likelihood of nerve preservation during treatment and thus may potentially temporarily prevent the onset of moderate to severe PN symptoms induced by chemotherapy in the hands and feet while receiving treatment
Conditions Studied
Interventions
- DEVICE Sham device
- DEVICE The Lilac Device
Study Locations (8)
Ohio
- Springfield Regional Cancer Center - Springfield
- Mercy Health St. Elizabeth Hospital - Youngstown
California
- Palomar Medical Center Poway - Poway
Florida
- Hialeah Hospital - Hialeah
Hawaii
- Hawaii Cancer Care - Honolulu
Illinois
- Hope and Healing Cancer Services - Hinsdale
Minnesota
- Health Partners Frauenshuh Cancer Center - Minneapolis
Wisconsin
- Hospital Sisters Health System - St.Vincent & St.Mary's - Green Bay
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 2025-10-03 |
| Est. Completion | 2026-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07142304
The ClinicalTrials.gov registry entry for NCT07142304 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 142 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Luminate Medical, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Chemotherapy Induced Peripheral Neuropathy (CIPN) appearing as the primary indexed condition, and to 2 interventions - of which Sham device is the first listed.
NCT07142304 reports 8 study locations spanning 7 distinct geographic areas - top geographies include Ohio, California, Florida.
Frequently Asked Questions
What is clinical trial NCT07142304 about?
NCT07142304 is a clinical study titled "The Lilac Device Trial". Chemotherapy drugs, used in the treatment of cancer, have the potential of inducing peripheral neuropathy (PN) as a side effect. This side effect is commonly referred to as CIPN, or chemotherapy-induced peripheral neuropathy. The Lilac Glove and Boot devices apply a low pressure across the surface ...
What is the current status of trial NCT07142304?
This trial is currently recruiting. It is a NA study. The enrollment target is 142 participants. The study started on 2025-10-03. Estimated completion is 2026-10.
What conditions does trial NCT07142304 study?
This clinical trial studies the following conditions: Chemotherapy Induced Peripheral Neuropathy (CIPN).
What interventions are being tested in trial NCT07142304?
The interventions under investigation include: Sham device (DEVICE), The Lilac Device (DEVICE).
Who is sponsoring clinical trial NCT07142304?
This trial is sponsored by Luminate Medical, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07142304 being conducted?
This trial has 8 study locations across California, Florida, Hawaii, Illinois, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chemotherapy Induced Peripheral Neuropathy (CIPN)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.